RBP4 and Insulin resistance: Furthermore, a 10-year follow-up prospective study of 3445 school-aged children revealed that participants with higher childhood RBP4 levels had adverse cardiometabolic profiles at follow-up and that baseline RBP4 levels predicted hyperglycemia and insulin resistance in the 10-year follow-up phase, independent of baseline BMI [84].